Aug 08, 2011 10:45am EDT 22nd Century Enrolls First Patients in X-22 Phase II-B Smoking Cessation Clinical Trial
Jun 22, 2011 4:26am EDT 22nd Century Files Investigational New Drug Application and Fast Track Request for X-22; Phase II-B Clinical Trial to Commence Immediately Upon FDA Clearance
Jun 08, 2011 9:42am EDT 22nd Century Doubles Acres Planted of Proprietary Tobacco; New Crop Will Increase Tobacco Inventory for Approximately $90 Million in Potential Sales of Finished Products
May 16, 2011 4:00am EDT 22nd Century Group Files First Quarter Report, Engages Redington, Inc. as Investor Relations Firm
